The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.
The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and education programme of the Congress. The industry has no influence on the content of the programme or speaker selection. All ESMO Colloquia are open to multi-sponsor support and interested sponsors can contact ESMO for more information on future programmes at colloquia@esmo.org
View the ELCC 2023 congress programme
Thursday, 30 March 2023
Precision Oncology beyond EGFR/ALK for NSCLC in 2023: test, target, manage
9:15-10:45 CEST (Central European Summer Time)
Auditorium 4
View the ESMO Colloquium details
This educational activity is provided by ESMO and supported by Eli Lilly and Company
Learning Objectives
- To provide an update on the evidence for clinical benefit from precision therapeutics in patients with NSCLC
- To present current indications for multiplex NGS tumour testing for actionable biomarkers in NSCLC
- To highlight NGS implementation challenges related to analytics, availability, reporting and interpretation